Cramer's Top Stock Picks: REGN PFE BIIB GLD

SPDR Gold continues to shine, Cramer said, and Regeneron, Pfizer and Biogen are worthy of investment.

Scott Rutt

Jan 9, 2013 6:00 AM EST

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK ( TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Tuesday's "Mad Money" on CNBC:

REGN data by YCharts

Regeneron Pharmaceuticals ( REGN):Cramer interviewed this company's CEO and once again recommended the stock because of its fantastic pipeline of new drugs.

If you liked this article you might like

UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.

Laura Board

Sep 22, 2016 9:56 AM EDT

The $639 million deal marks the the third purchase for Brent Saunders since early August.

Sarah Pringle

Sep 14, 2016 2:56 PM EDT

Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) said today that trials of their cholesterol drug Praulent met targets.

Annie Palmer

Aug 29, 2016 2:39 PM EDT

Pfizer's $14 billion acquisition of Medivation is a strong purchase, according to Jim Cramer, who now wonders what Sanofi will do next.

Rhonda Schaffler

Aug 22, 2016 12:12 PM EDT

SUBSCRIPTION SERVICES

SUBSCRIPTION BUNDLES

FREE

Real Money

Can't Get New Movies or Bull Charts from Netflix

Cramer's Top Stock Picks: REGN PFE BIIB GLD

SPDR Gold continues to shine, Cramer said, and Regeneron, Pfizer and Biogen are worthy of investment.

If you liked this article you might like

Trending

Advertising Partners

Email Newsletters

Can't Get New Movies or Bull Charts from Netflix

If you liked this article you might like

New Setback for Sanofi's Lantus Increases Need for M&A

Allergan's Dealmaking Continues With Vitae Takeout

How Will Regeneron (REGN) Stock React to Cholesterol Drug Trial Success?

Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back

Trending

Advertising Partners